February 2025, From the Field
Our approach as active managers is to try to add value in a variety of ways, from fundamental research to quantitative analysis to a superior asset allocation mix. One of the core tenets of our approach to active management is identifying and exploiting what we believe to be durable market inefficiencies—that is to say, market segments where the price of an asset doesn’t correctly reflect its value. In this piece, the second of a three‑part series, we examine a selection of these inefficiencies.
When we analyze the investable universe of U.S. large-cap stocks, we begin by eliminating names that have what we consider to be fundamental flaws—such as poor capital allocation and poor management teams. This process narrows the S&P 500 Index from about 500 stocks to approximately 125 that we think have better odds of outperforming over the long term. Within this narrower universe, we have often found that the most compelling opportunities have several factors in common, and we define these companies as growth-at-a-reasonable-price (GARP) stocks. This segment of the market has generated significantly higher cumulative returns than the broader market over the last three decades (Fig. 1).
Data reflect the period beginning January 1, 1995, through December 31, 2024.
GARP stocks are identified through a proprietary process from within the S&P 500 Index. We rank each name within the index according to various factors to produce an equal-weighted composite of those factor ranks. From this, we identify GARP stocks as those which offer the cheapest valuations and highest growth factors. The resulting basket of GARP stocks shown are for illustrative purposes only and do not represent an actual investment.
Sources: Analysis by T. Rowe Price Investment Management, FactSet.
Performance quoted represents past performance which is not a guarantee or a reliable indicator of future results. Index performance is for illustrative purposes only and is not indicative of any specific investment. Investors cannot invest directly in an index.
Our analysis demonstrates that these stocks have not only generated better absolute returns, but they have also tended to trade at a discount and grow earnings faster than the broader equity market. They have also outperformed the S&P 500 Index across a wide range of market environments. In all, we think these companies make up only about 10% of the S&P 500 Index. As we look at the ocean that is the investable universe, we believe strongly in casting our line into the pond of GARP stocks.
When we say a stock is trading at a discount, we mean simply that it is trading below the value we believe is indicated by the company’s underlying fundamentals. One key measure we consider in evaluating the fair value of a company’s shares is its next 12-months’ price-to-earnings ratio (NTM P/E). By dividing the price a stock is trading at today by the projected earnings of the company over the next 12 months, based on consensus estimates, we arrive at the company’s multiple. As an example in practice, an NTM P/E ratio of 15x tells us that the price of a stock today is 15 times its projected earnings per share over the next 12 months. This multiple gives us a key point of comparison for a company relative to its competitors, its sector, and the market.
Part of what makes GARP stocks so attractive to us as portfolio managers is that the multiple for this market segment is consistently and meaningfully lower than the broader market. Put simply, we believe we are paying less for future earnings when we are buying these kinds of stocks (Fig. 2).
Another key measure of corporate fundamentals that separates GARP stocks from the broader market is return on equity (ROE). ROE measures the net income reported by a company relative to its shareholder equity to provide a view of profitability, where a higher ROE represents greater profitability. While only one measure, a high ROE can indicate that a company allocates capital effectively and is likely to generate excess returns that can create shareholder value through reinvestment, stock buybacks, and dividends. GARP stocks have typically offered a significantly higher ROE and typically lower earnings variability than the equity market (Fig. 3). Considering these factors, we think GARP stocks are an opportunity to buy shares of more profitable and better managed companies at a material discount.
Data reflect the period beginning January 1, 1995, through December 31, 2024.
Sources: Analysis by T. Rowe Price Investment Management, FactSet.
Refer to the prior figure for how we determine the calculation for GARP stocks.
Moving average is a calculation to produce the mean of a set of values over a specified period to identify longer-term trends and minimize the impact of short-term fluctuations.
Actual future outcomes may differ materially from estimates.
Data reflect the period beginning January 1, 1995, through December 31, 2024.
Sources: Analysis by T. Rowe Price Investment Management, FactSet.
Refer to the prior figures for how we determine the calculation for GARP stocks and the moving average definition.
Companies that we find fit our definition of a GARP stock are often not household names. One such example is Danaher, which we own in the Capital Appreciation Fund, Capital Appreciation and Income Fund, and Capital Appreciation Equity ETF.1 Danaher is a medical and industrial conglomerate that has leading positions in life sciences tools and diagnostics. While Danaher has not offered the explosive growth we have observed from names in semiconductors or software, the stock has had more consistent earnings growth and been less volatile than the broader market over the last decade.2 These attributes are central to our focus on GARP stocks. In Danaher, we see a company that has tended to allocate capital exceptionally well, through acquisitions of companies that had faster organic growth rates than their core business, for example. We also have seen that management has focused on investing in research and development to drive future growth, increasing market share and improving margins, and divesting noncore businesses. These actions supported profitability over the long term and are the types of behaviors that tended to create shareholder value.
In the funds we manage,3 investing in this segment of GARP stocks is a core tenet of our investment process and a key way in which we seek to generate alpha. We think this inefficiency has continued to exist because there is no natural buyer for GARP stocks, which has allowed us to typically purchase these stocks at a discount.
Given the discount we have observed for these stocks, and their demonstrably higher ROE, it follows that these stocks would tend to perform better than the broader market over longer time periods. What makes them even more attractive to us, as portfolio managers, is that GARP stocks have generated not only better absolute returns, but better risk‑adjusted returns (as measured by the Sharpe ratio from 1990–2024).
As portfolio managers, we are willing to go against consensus, question commonly held assumptions, and follow through on our research and process. Identifying and investing in GARP stocks offers one such opportunity to go against the grain and pursue attractive risk-adjusted returns in an area we think the market underappreciates and misunderstands. Through fundamental research, taking a longer view, and asking the right questions, we are committed to uncovering opportunities that can add value for our shareholders.
Farris Shuggi is the head of quantitative equity at T. Rowe Price Investment Management (TRPIM) and co-portfolio manager for the Capital Appreciation and Income Fund under the Capital Appreciation Strategy. He is the cochairman and a member of the Capital Appreciation and Income Investment Advisory Committee; a member of the Capital Appreciation, Capital Appreciation Equity ETF, and Small-Cap Value Investment Advisory Committees; and a member of the TRPIM ESG Investing Committee. Farris is a vice president of T. Rowe Price Group, Inc.
David Giroux is a portfolio manager for the Capital Appreciation Strategy, including the Capital Appreciation Fund and Capital Appreciation Equity ETF, and co-portfolio manager for the Capital Appreciation and Income Fund at T. Rowe Price Investment Management (TRPIM). He also is head of Investment Strategy and chief investment officer for T. Rowe Price Investment Management. David is the chairman of the Capital Appreciation and Capital Appreciation Equity ETF Investment Advisory Committees and a cochairman of the Capital Appreciation and Income Investment Advisory Committee. He is a member of the TRPIM ESG Investing and Investment Steering Committees. David also is a vice president of T. Rowe Price Group, Inc.
Kevin Klassen is a quantitative investment analyst at T. Rowe Price Investment Management. He is a vice president of T. Rowe Price Investment Management, Inc.
Performance quoted represents past performance which is not a guarantee or a reliable indicator of future results. Index performance is for illustrative purposes only and is not indicative of any specific investment. Investors cannot invest directly in an index.
1 As of December 31, 2024, Danaher’s weight within the Capital Appreciation Fund was 1.81%, within the Capital Appreciation and Income Fund was 0.39%, and within the Capital Appreciation Equity ETF was 1.98%.
2 For the 10-year period ended December 31, 2024, Danaher’s beta relative to the S&P 500 Index was 0.85. Beta is a measure of volatility, where a number less than 1 indicates lower volatility and a number higher than 1 indicates higher volatility relative to a benchmark.
3 David Giroux is the portfolio manager of the Capital Appreciation Fund, Capital Appreciation and Income Fund, and Capital Appreciation Equity ETF (Exchange Traded Fund). Farris Shuggi is the co-portfolio manager of the Capital Appreciation and Income Fund. Kevin Klassen is a quantitative analyst supporting the management of all three funds.
4 A measure of the risk-adjusted return of a portfolio. The Sharpe ratio measures how much a portfolio’s return is above or below the “risk-free” rate (excess return) per unit risk (measured by standard deviation). In general, the larger the number, the better the portfolio’s historical risk-adjusted return. Refer to the prior figures for how we determine the calculation for GARP stocks.
5 Calculated for GARP stocks and the S&P 500 based on the Treasury rate as the “risk-free rate”, annualized returns, and annualized standard deviation of daily returns for the period from January 1, 1990–December 31, 2024.
6 Based on downside capture, which examines the geometric mean of GARP stocks and the S&P 500 Index on all days wherein the S&P 500 Index generated a negative return for the stated periods. This allows a comparison of the geometric mean of losses for GARP stocks and the S&P 500 Index.
7 A peak-to-trough decline during a specific period of time.
8 The average recovery from trough to peak for GARP stocks was 370 days, while the average recovery for the S&P 500 Index over the same period was 684 days.
Important Information
Call 1-800-225-5132 to request a prospectus or summary prospectus; each includes investment objectives, risks, fees, expenses, and other information you should read and consider carefully before investing.
ETFs are bought and sold at market prices, not net asset value (NAV). Investors generally incur the cost of the spread between the prices at which shares are bought and sold. Buying and selling shares may result in brokerage commissions, which will reduce returns.
The T. Rowe Price Capital Appreciation Fund, Capital Appreciation and Income Fund and Capital Appreciation Equity ETF share the same lead portfolio manager and investment research process. However, the funds’ implementation of the research process varies including, but not limited to, differences in product structure, asset allocation, trading, and fees and expenses. There is no guarantee that the funds will perform similarly in any market environment. Review the prospectuses for detailed information on the funds’ strategy, fees, and risks.
Risks: All investments are subject to risks, including the possible loss of principal.
Capital Appreciation Equity ETF: The ETF is subject to the inherent volatility of common stock investing. The fund’s value and growth investing styles may become out of favor, which may result in periods of underperformance. The fund is “nondiversified,” meaning it may invest a greater portion of its assets in a single company and own more of the company’ voting securities than is permissible for a “diversified” fund. The fund’s share price can be expected to fluctuate more than that of a comparable diversified fund.
Capital Appreciation Fund: The fund is subject to the inherent volatility of common stock investing. The value approach carries the risk that the market will not recognize a security’s intrinsic value for a long time or that a stock judged to be undervalued may actually be appropriately priced. Because of the fund’s fixed‑income holdings or cash position, it may not keep pace in a rapidly rising market.
Capital Appreciation and Income Fund: The fund is subject to the inherent volatility of common stock investing. Fixed‑income securities are subject to credit risk, liquidity risk, call risk, and interest‑rate risk. As interest rates rise, bond prices generally fall.
This material is provided for informational purposes only and is not intended to be investment advice or a recommendation to take any particular investment action.
The views contained herein are those of the authors as of February 2025 and are subject to change without notice; these views may differ from those of other T. Rowe Price associates.
This information is not intended to reflect a current or past recommendation concerning investments, investment strategies, or account types, advice of any kind, or a solicitation of an offer to buy or sell any securities or investment services. The opinions and commentary provided do not take into account the investment objectives or financial situation of any particular investor or class of investor. Please consider your own circumstances before making an investment decision.
Information contained herein is based upon sources we consider to be reliable; we do not, however, guarantee its accuracy. Actual future outcomes may differ materially from any estimates or forward-looking statements provided.
Performance quoted represents past performance which is not a guarantee or a reliable indicator of future results. All investments are subject to market risk, including the possible loss of principal. All charts and tables are shown for illustrative purposes only.
T. Rowe Price Investment Services, Inc.
© 2025 T. Rowe Price. All Rights Reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, and the Bighorn Sheep design are, collectively and/or apart, trademarks of T. Rowe Price Group, Inc.